Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Amortization of Deferred Charges (2022 - 2026)

Masimo's quarterly Amortization of Deferred Charges came in at $300000.0 in Q2 2026, down 40.0% year-on-year from $500000.0 in Q2 2025, and down 57.14% quarter-over-quarter from $700000.0 in Q1 2026.

Masimo has reported Amortization of Deferred Charges for 5 years, with the latest figure at $300000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Amortization of Deferred Charges fell 40.0% year-over-year to $300000.0; the trailing twelve-month figure through Apr 2026 stood at $2.8 million (up 47.37% YoY), and the FY2026 full-year result was $3.0 million, up 57.89% from the prior year.
  • Amortization of Deferred Charges for Q2 2026 stood at $300000.0, down from $700000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.4 million in Q3 2025, with the low at $300000.0 in Q2 2026.
  • Average Amortization of Deferred Charges over 5 years is $566666.7, with a median of $500000.0 recorded in 2022.
  • Year-over-year, Amortization of Deferred Charges plunged 44.44% in 2023 and jumped 180.0% in 2025.
  • Tracing MASI's Amortization of Deferred Charges over 5 years: stood at $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then soared by 180.0% to $1.4 million in 2025, then plunged by 78.57% to $300000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $300000.0 (Q2 2026), $700000.0 (Q1 2026), and $1.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 300,000.00
Apr 4, 2026 300,000.00
Jan 3, 2026 700,000.00
Jan 3, 2026 700,000.00
Sep 27, 2025 1.40 Mn
Sep 27, 2025 1.40 Mn
Jun 28, 2025 400,000.00
Jun 28, 2025 400,000.00
Mar 29, 2025 500,000.00
Mar 29, 2025 500,000.00
Dec 28, 2024 500,000.00
Dec 28, 2024 500,000.00
Sep 28, 2024 500,000.00
Sep 28, 2024 500,000.00
Jun 29, 2024 400,000.00
Jun 29, 2024 400,000.00
Mar 30, 2024 500,000.00
Mar 30, 2024 500,000.00
Dec 30, 2023 500,000.00
Dec 30, 2023 500,000.00
Sep 30, 2023 500,000.00
Sep 30, 2023 500,000.00
Jul 1, 2023 400,000.00
Jul 1, 2023 400,000.00
Apr 1, 2023 500,000.00
Apr 1, 2023 500,000.00
Dec 31, 2022 500,000.00
Dec 31, 2022 500,000.00
Oct 1, 2022 900,000.00
Oct 1, 2022 900,000.00